One answer is the health care industry: By turning people into patients, screening makes a lot of money for pharmaceutical companies, hospitals and doctors.
Nonetheless, sFOV-CBCT is not meant to be a replacement for PAN especially for patients' screening.
Inclusion criteria were as follows: age >18 years old, intubation within 24 h, expected intubation longer than 48 h, and FiO2 <80 % at the moment of patients screening.
Given the elevated risk of cardiovascular events and the higher prevalence of silent coronary artery disease (CAD) in diabetic versus non-diabetic patients, screening asymptomatic diabetic patients for CAD is an appealing concept.
For the study purpose, each subunit was subsequently included and monitored during a 3-month period for patients' screening and the recruitment: from 1 April to 30 June 2013, the medical subunit, from 1 July to 30 September 2013, the traumatology subunit and from 1st October to 31st December 2013, the respiratory subunit.
For Asian patients, screening prevalence did not change significantly over the 3 periods; for Black patients, screening prevalence increased over the 3 periods (Table 3).
Patients screening positive were invited to take part in the study.
Female patients comprised the majority of patients screening positive for both lifetime and 12 month IPV.
Given the increased risk imposed on FDRs of CRC patients, screening for CRC assumes major importance.
PCPs offered patients screening on an ad-hoc basis during primary care visits.
